Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Under section 34 of the Medicines and Poisons Act 2019, currently the maximum penalty is a $32,260 fine
Doi: 23
NCT02205528 was a Phase 2 clinical trial of NNC0090-2746, and was designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled trial with open-label comparison, performed in patients with T2DM inadequately controlled with metformin (108 participants, 12 withdrew prematurely from the trial, 96 completed)
Despite the pharmacokinetic challenges posed by the low systemic bioavailability of key withanolides in human plasma, their substantial in vivo effectiveness seems to result from multiple interconnected mechanisms
US$ 20.67
US$ 23.94
US$ 21.21
